Mindful Eating for Patients with Anxiety and Obesity
Evaluation of the Effect of Mindful Eating in Patients With Anxiety and Obesity.
This study tests if a Mindful Eating program can help adults with anxiety and obesity improve their eating habits and feel less emotional distress over five weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 52 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | Hospital de Clinicas de Porto Alegre Academic / other |
| Locations | 1 site (Porto Alegre, Rio Grande Do Sul) |
| Trial ID | NCT06087185 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a Mindful Eating intervention on neurocognitive and behavioral outcomes in adults with obesity and anxiety. Participants will be randomly assigned to either the Mindful Eating group or a control group that watches videos promoting quality of life. The intervention lasts for five weeks and aims to improve eating behaviors and reduce emotional distress associated with obesity. The study is conducted at the Hospital de Clínicas de Porto Alegre and involves 52 adult participants.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 50 with a diagnosis of Generalized Anxiety Disorder and obesity (BMI between 30.0 and 39.9).
Not a fit: Patients with other psychiatric disorders, severe depression, or those currently undergoing psychopharmacological or nutritional treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could help patients improve their eating behaviors and manage anxiety, leading to better obesity treatment outcomes.
How similar studies have performed: Other studies have shown promising results with Mindful Eating interventions, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be between 18 and 50 years old; * Inclusion for Generalized Anxiety Disorder (GAD): Primary GAD diagnosed by the M.I.N.I.; ✔Inclusion for Obesity: Obesity BMI grade I (between 30.0 and 34.9); Obesity BMI grade II (between 35.0 and 39.9) Exclusion Criteria: * In individuals with obesity or control only, not having any psychiatric disorder; * In individuals with only GAD or control, do not have a BMI above 25. * In individuals with GAD, not having a diagnosis of primary or severe depression; * Being under psychopharmacological, psychotherapeutic or nutritional treatment; * Bipolar Disorder, Psychotic Disorder, Substance Use Disorder (except Tobacco) in the last 6 months or Suicidal Ideation in the last 6 months (M.I.N.I); * Have a clinical instability or immobility; * Being in Pregnancy or Lactation; * Antisocial Personality Disorder; * Eating Disorder.
Where this trial is running
Porto Alegre, Rio Grande Do Sul
- Hospital de Clínicas de Porto Alegre — Porto Alegre, Rio Grande Do Sul, Brazil (Recruiting)
Study contacts
- Study coordinator: Natasha KO Fonseca, MsC
- Email: natashakof@gmail.com
- Phone: 5554991912372
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.